Warning: The NCBI web site requires JavaScript to function. more...
Characterization of a potent non-cytotoxic shRNA directed to the HIV-1 co-receptor CCR5.
Shimizu S, Kamata M, Kittipongdaja P, Chen KN, Kim S, Pang S, Boyer J, Qin FX, An DS, Chen IS.
Genet Vaccines Ther. 2009 Jun 10;7:8.
Related citations
Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors.
An DS, Qin FX, Auyeung VC, Mao SH, Kung SK, Baltimore D, Chen IS.
Mol Ther. 2006 Oct;14(4):494-504. Epub 2006 Jul 17.
Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection.
Anderson J, Akkina R.
Gene Ther. 2007 Sep;14(17):1287-97. Epub 2007 Jun 28.
Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors.
Fish RJ, Kruithof EK.
BMC Mol Biol. 2004 Aug 3;5:9.
Titers of HIV-based vectors encoding shRNAs are reduced by a dicer-dependent mechanism.
Poluri A, Sutton RE.
Mol Ther. 2008 Feb;16(2):378-86. Epub 2007 Dec 11.
Construction of simple and efficient DNA vector-based short hairpin RNA expression systems for specific gene silencing in mammalian cells.
Cheng TL, Chang WT.
Methods Mol Biol. 2007;408:223-41.
Stringent testing identifies highly potent and escape-proof anti-HIV short hairpin RNAs.
von Eije KJ, ter Brake O, Berkhout B.
J Gene Med. 2009 Jun;11(6):459-67.
Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition.
ter Brake O, 't Hooft K, Liu YP, Centlivre M, von Eije KJ, Berkhout B.
Mol Ther. 2008 Mar;16(3):557-64. Epub 2008 Jan 15.
Comparison of chicken 7SK and U6 RNA polymerase III promoters for short hairpin RNA expression.
Bannister SC, Wise TG, Cahill DM, Doran TJ.
BMC Biotechnol. 2007 Nov 19;7:79.
[Deep lung--cellular reaction to HIV].
Tavares Marques MA, Alves V, Duque V, Botelho MF.
Rev Port Pneumol. 2007 Mar-Apr;13(2):175-212. Review. Portuguese.
Rapid assessment of anti-HIV siRNA efficacy using PCR-derived Pol III shRNA cassettes.
Scherer LJ, Yildiz Y, Kim J, Cagnon L, Heale B, Rossi JJ.
Mol Ther. 2004 Sep;10(3):597-603.
96 shRNAs designed for maximal coverage of HIV-1 variants.
McIntyre GJ, Groneman JL, Yu YH, Jaramillo A, Shen S, Applegate TL.
Retrovirology. 2009 Jun 4;6:55.
Inhibition of HIV-1 infection by a unique short hairpin RNA to chemokine receptor 5 delivered into macrophages through hematopoietic progenitor cell transduction.
Liang M, Kamata M, Chen KN, Pariente N, An DS, Chen IS.
J Gene Med. 2010 Mar;12(3):255-65.
Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic.
Giering JC, Grimm D, Storm TA, Kay MA.
Mol Ther. 2008 Sep;16(9):1630-6. Epub 2008 Jul 29.
CXCR4 and CCR5 shRNA transgenic CD34+ cell derived macrophages are functionally normal and resist HIV-1 infection.
Retrovirology. 2005 Aug 18;2:53.
Selection of potent non-toxic inhibitory sequences from a randomized HIV-1 specific lentiviral short hairpin RNA library.
Pongratz C, Yazdanpanah B, Kashkar H, Lehmann MJ, Kräusslich HG, Krönke M.
PLoS One. 2010 Oct 8;5(10):e13172.
Silencing of HIV-1 with RNA interference: a multiple shRNA approach.
ter Brake O, Konstantinova P, Ceylan M, Berkhout B.
Mol Ther. 2006 Dec;14(6):883-92. Epub 2006 Sep 7.
[RNA interference directed by small hairpin RNA expressed in COS-7 cells].
Tang FC, Yang HB, Meng GL, Li CJ, Shang KG, Zhang B, Xue YF.
Yi Chuan Xue Bao. 2003 Apr;30(4):295-300. Chinese.
A quick and efficient approach for gene silencing by using triple putative microRNA-based short hairpin RNAs.
Shan ZX, Lin QX, Yang M, Deng CY, Kuang SJ, Zhou ZL, Xiao DZ, Liu XY, Lin SG, Yu XY.
Mol Cell Biochem. 2009 Mar;323(1-2):81-9. Epub 2008 Nov 27.
Investigation of transcriptional gene silencing and mechanism induced by shRNAs targeted to RUNX3 in vitro.
Feng XZ, He XS, Zhuang YZ, Luo Q, Jiang JH, Yang S, Tang XF, Liu JL, Chen T.
World J Gastroenterol. 2008 May 21;14(19):3006-14.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on